The influence of chronic antihypertensive treatment on the central pressor response in SHR

Y. Lin, T. Tsuchihashi, S. Kagiyama, K. Matsumura, I. Abe

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

We examined the influence of chronic antihypertensive treatment on the central pressor response in SHR. Adult male SHR were divided into 5 groups, i.e., those receiving 1) enalapril (Enal: 25 mg/kg/day in drinking water, n=12); 2) losartan (Los: 40 mg/kg/day, n=11); 3) candesartan (Cand: 4 mg/kg/day, n=12); 4) hydralazine+hydrochlorothiazide (H&H: 50+7.5 mg/kg/day, n=9); 5) vehicle (Control: n=9). At 4 weeks of treatment, hypertonic saline (0.25, 0.5 M) was intracerebroventricularly (i.c.v.) injected into conscious rats. Plasma catecholamines were measured before and after i.c.v. injection. On completion of the experiment, heart weight was measured, and angiotensin-converting enzyme (ACE) activity of the cerebrum was determined. All antihypertensive drugs elicited comparable reductions in systolic blood pressure, while heart rate was significantly higher in the H&H group than in the other groups during treatment. Pressor response to i.c.v. hypertonic saline (0.5 M) was significantly smaller in the Enal (12±3 mmHg) and Cand (11 ±2 mmHg) groups than in the Los (22±2 mmHg), H&H (16±2 mmHg), and Control (29±5 mmHg) groups. Plasma catecholamines did not differ among the groups. Heart weight was lowest in the Enal group, followed by the Los and Cand groups. ACE activity of the cerebrum was significantly decreased in the Enal group. The results suggest that chronic treatment with various antihypertensive drugs differentially alters the central pressor response in SHR, and enalapril and candesartan are effective in attenuating this response.

Original languageEnglish
Pages (from-to)173-178
Number of pages6
JournalHypertension Research
Volume24
Issue number2
DOIs
Publication statusPublished - May 8 2001

Fingerprint

Antihypertensive Agents
Enalapril
Cerebrum
Peptidyl-Dipeptidase A
Catecholamines
Blood Pressure
Weights and Measures
Hydralazine
Hydrochlorothiazide
Losartan
Therapeutics
Drinking Water
Heart Rate
Injections
candesartan

All Science Journal Classification (ASJC) codes

  • Internal Medicine
  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

The influence of chronic antihypertensive treatment on the central pressor response in SHR. / Lin, Y.; Tsuchihashi, T.; Kagiyama, S.; Matsumura, K.; Abe, I.

In: Hypertension Research, Vol. 24, No. 2, 08.05.2001, p. 173-178.

Research output: Contribution to journalArticle

Lin, Y, Tsuchihashi, T, Kagiyama, S, Matsumura, K & Abe, I 2001, 'The influence of chronic antihypertensive treatment on the central pressor response in SHR', Hypertension Research, vol. 24, no. 2, pp. 173-178. https://doi.org/10.1291/hypres.24.173
Lin, Y. ; Tsuchihashi, T. ; Kagiyama, S. ; Matsumura, K. ; Abe, I. / The influence of chronic antihypertensive treatment on the central pressor response in SHR. In: Hypertension Research. 2001 ; Vol. 24, No. 2. pp. 173-178.
@article{33c3fb8cbb9b4964ac00b8e9a0fa89bf,
title = "The influence of chronic antihypertensive treatment on the central pressor response in SHR",
abstract = "We examined the influence of chronic antihypertensive treatment on the central pressor response in SHR. Adult male SHR were divided into 5 groups, i.e., those receiving 1) enalapril (Enal: 25 mg/kg/day in drinking water, n=12); 2) losartan (Los: 40 mg/kg/day, n=11); 3) candesartan (Cand: 4 mg/kg/day, n=12); 4) hydralazine+hydrochlorothiazide (H&H: 50+7.5 mg/kg/day, n=9); 5) vehicle (Control: n=9). At 4 weeks of treatment, hypertonic saline (0.25, 0.5 M) was intracerebroventricularly (i.c.v.) injected into conscious rats. Plasma catecholamines were measured before and after i.c.v. injection. On completion of the experiment, heart weight was measured, and angiotensin-converting enzyme (ACE) activity of the cerebrum was determined. All antihypertensive drugs elicited comparable reductions in systolic blood pressure, while heart rate was significantly higher in the H&H group than in the other groups during treatment. Pressor response to i.c.v. hypertonic saline (0.5 M) was significantly smaller in the Enal (12±3 mmHg) and Cand (11 ±2 mmHg) groups than in the Los (22±2 mmHg), H&H (16±2 mmHg), and Control (29±5 mmHg) groups. Plasma catecholamines did not differ among the groups. Heart weight was lowest in the Enal group, followed by the Los and Cand groups. ACE activity of the cerebrum was significantly decreased in the Enal group. The results suggest that chronic treatment with various antihypertensive drugs differentially alters the central pressor response in SHR, and enalapril and candesartan are effective in attenuating this response.",
author = "Y. Lin and T. Tsuchihashi and S. Kagiyama and K. Matsumura and I. Abe",
year = "2001",
month = "5",
day = "8",
doi = "10.1291/hypres.24.173",
language = "English",
volume = "24",
pages = "173--178",
journal = "Hypertension Research",
issn = "0916-9636",
publisher = "Nature Publishing Group",
number = "2",

}

TY - JOUR

T1 - The influence of chronic antihypertensive treatment on the central pressor response in SHR

AU - Lin, Y.

AU - Tsuchihashi, T.

AU - Kagiyama, S.

AU - Matsumura, K.

AU - Abe, I.

PY - 2001/5/8

Y1 - 2001/5/8

N2 - We examined the influence of chronic antihypertensive treatment on the central pressor response in SHR. Adult male SHR were divided into 5 groups, i.e., those receiving 1) enalapril (Enal: 25 mg/kg/day in drinking water, n=12); 2) losartan (Los: 40 mg/kg/day, n=11); 3) candesartan (Cand: 4 mg/kg/day, n=12); 4) hydralazine+hydrochlorothiazide (H&H: 50+7.5 mg/kg/day, n=9); 5) vehicle (Control: n=9). At 4 weeks of treatment, hypertonic saline (0.25, 0.5 M) was intracerebroventricularly (i.c.v.) injected into conscious rats. Plasma catecholamines were measured before and after i.c.v. injection. On completion of the experiment, heart weight was measured, and angiotensin-converting enzyme (ACE) activity of the cerebrum was determined. All antihypertensive drugs elicited comparable reductions in systolic blood pressure, while heart rate was significantly higher in the H&H group than in the other groups during treatment. Pressor response to i.c.v. hypertonic saline (0.5 M) was significantly smaller in the Enal (12±3 mmHg) and Cand (11 ±2 mmHg) groups than in the Los (22±2 mmHg), H&H (16±2 mmHg), and Control (29±5 mmHg) groups. Plasma catecholamines did not differ among the groups. Heart weight was lowest in the Enal group, followed by the Los and Cand groups. ACE activity of the cerebrum was significantly decreased in the Enal group. The results suggest that chronic treatment with various antihypertensive drugs differentially alters the central pressor response in SHR, and enalapril and candesartan are effective in attenuating this response.

AB - We examined the influence of chronic antihypertensive treatment on the central pressor response in SHR. Adult male SHR were divided into 5 groups, i.e., those receiving 1) enalapril (Enal: 25 mg/kg/day in drinking water, n=12); 2) losartan (Los: 40 mg/kg/day, n=11); 3) candesartan (Cand: 4 mg/kg/day, n=12); 4) hydralazine+hydrochlorothiazide (H&H: 50+7.5 mg/kg/day, n=9); 5) vehicle (Control: n=9). At 4 weeks of treatment, hypertonic saline (0.25, 0.5 M) was intracerebroventricularly (i.c.v.) injected into conscious rats. Plasma catecholamines were measured before and after i.c.v. injection. On completion of the experiment, heart weight was measured, and angiotensin-converting enzyme (ACE) activity of the cerebrum was determined. All antihypertensive drugs elicited comparable reductions in systolic blood pressure, while heart rate was significantly higher in the H&H group than in the other groups during treatment. Pressor response to i.c.v. hypertonic saline (0.5 M) was significantly smaller in the Enal (12±3 mmHg) and Cand (11 ±2 mmHg) groups than in the Los (22±2 mmHg), H&H (16±2 mmHg), and Control (29±5 mmHg) groups. Plasma catecholamines did not differ among the groups. Heart weight was lowest in the Enal group, followed by the Los and Cand groups. ACE activity of the cerebrum was significantly decreased in the Enal group. The results suggest that chronic treatment with various antihypertensive drugs differentially alters the central pressor response in SHR, and enalapril and candesartan are effective in attenuating this response.

UR - http://www.scopus.com/inward/record.url?scp=0035032039&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0035032039&partnerID=8YFLogxK

U2 - 10.1291/hypres.24.173

DO - 10.1291/hypres.24.173

M3 - Article

C2 - 11325077

AN - SCOPUS:0035032039

VL - 24

SP - 173

EP - 178

JO - Hypertension Research

JF - Hypertension Research

SN - 0916-9636

IS - 2

ER -